Analyzing histamine H4 receptor-mediated effects in whole blood

Details for Australian Patent Application No. 2004276820 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Thurmond, Robin; Leung, Wai-Ping; Karlsson, Lars; Ling, Ping

Agent Shelston IP

Pub. Number AU-A-2004276820

PCT Pub. Number WO2005/031308

Priority 60/506,434 26.09.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/031308 Priority application(s): WO2005/031308

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276821-Novel therapeutic targets in cancer

2004276819-Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs